Sarada Weerasinghe

Sarada Weerasinghe is a seasoned finance professional with extensive experience in corporate financial planning and analysis. Currently serving as the Sr. Corporate Financial Planning & Analysis Manager at Ascendis Pharma since February 2021, Sarada oversees a $50M accounting portfolio for clinical trials, focusing on cost evaluation and detailed analyses for C-suite presentations regarding FDA submissions. Previously, Sarada held managerial roles at Accela and Corcept Therapeutics, contributing significantly to financial planning and analysis functions. Early career experience includes serving as a Senior Assurance Associate at EY, where leadership was provided on audits for public and private companies, including notable transactions like the IPO of Quotient Technology Inc. Sarada holds an MBA from the University of California, Berkeley, and advanced degrees in accounting and finance from Michigan State University.